Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T00:42:18.676Z Has data issue: false hasContentIssue false
  • English
  • Français

Population-Based Surveillance of Clostridium difficile Infection in Manitoba, Canada, by Using Interim Surveillance Definitions

Published online by Cambridge University Press:  02 January 2015

Pascal J. Lambert ,
Myrna Dyck ,
Laura H. Thompson  and
Greg W. Hammond
Pascal J. Lambert
Affiliation:
Manitoba Health and Health Living, Winnipeg, Manitoba, Canada
Myrna Dyck
Affiliation:
Manitoba Health and Health Living, Winnipeg, Manitoba, Canada Department of Community Health Sciences, Winnipeg, Manitoba, Canada
Laura H. Thompson
Affiliation:
University of Manitoba, and the National Collaborating Centre for Infectious Diseases, Winnipeg, Manitoba, Canada
Greg W. Hammond*
Affiliation:
Department of Community Health Sciences, Winnipeg, Manitoba, Canada Department of Medical Microbiology, Winnipeg, Manitoba, Canada
*
University of Manitoba, Department of Medical Microbiology, 730 William Avenue, Winnipeg, MB, CanadaR3E 0W3 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

TO apply interim surveillance definitions of Clostridium difficile infection (CDI) cases to 1 year of data from the provincewide surveillance system of Manitoba, Canada, to determine the epidemiology of CDI incident cases in a population.

Methods.

CDI cases were categorized with interim surveillance definitions developed by an ad hoc C. difficile surveillance working group. Incident cases recorded in the provincial CDI database between July 2005 and June 2006 were linked to the provincial hospitalization and nursing home databases and analyzed.

Results.

One thousand six incident cases were identified over 1 year. Five hundred fifteen (51%) cases were associated with and began in a healthcare facility (HCF), whereas 275 (27%) were associated with and began in the community. An additional 131 (13%) cases were HCF associated but began in the community, while 85 (8%) were of indeterminate origin. Cases of HCF-associated CDI occurred in patients who were older than did cases of community-associated CDI (P < .0001). The provincial rate of community-onset cases was 23.4 per 100,000 person-years, and rates varied among geographic areas. HCF-associated CDI rates among the 10 largest hospitals varied from 0.5 to 8.4 per 10,000 patient-days. The time to CDI onset after hospital admission indicated that 25% of nosocomial cases began by the 8th day, and 50% began by the 17th day.

Conclusions.

Although the majority of CDI cases were associated with exposure to a HCF, 40% of incident CDI began in the community. Populations with HCF- and community-associated CDI demonstrated significantly different age distributions. The wide variation of rates among HCFs requires explanation. The high percentage of incident cases in the community warrants increased study.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 10 , October 2009 , pp. 945 - 951
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Chandler, RE, Hedberg, KH, Cieslak, PR. Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors. Infect Control Hosp Epidemiol 2007;28:116–122.CrossRefGoogle ScholarPubMed
2.Dallai, RM, Harbrecht, BG, Boujoukas, AJ, et al.Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363–372.CrossRefGoogle Scholar
3.Pépin, J, Valiquette, L, Alary, M-E, et al.Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466–472.CrossRefGoogle Scholar
4.Ricciardi, R, Rothenberger, DA, Madoff, RD, Baxter, NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized Patients. Arch Surg 2007;142:624–631.CrossRefGoogle ScholarPubMed
5.Zilberberg, MD, Shorr, AF, Kollef, MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14:929–931.CrossRefGoogle ScholarPubMed
6.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.CrossRefGoogle ScholarPubMed
7.Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005. MMWR Morb Mortal Wkly Rep 2005;54:1201–1205.Google Scholar
8.McDonald, LC, Coignard, B, Dubberke, E, et al.Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.CrossRefGoogle ScholarPubMed
9.Government of Manitoba. Manitoba population report: June 1, 2005. Winnipeg, MB, Canada: Health Information Management Branch; 2006.Google Scholar
10.Roos, LL, Gupta, S, Soodeen, RA, Jebamani, L. Data quality in an information-rich environment: Canada as an example. Can J Aging 2005;24(Suppl 1):153–170.CrossRefGoogle Scholar
11.Kutty, PK, Benoit, SR, Woods, CW, et al.Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008;29:197–202.CrossRefGoogle ScholarPubMed
12.Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989–2995.CrossRefGoogle ScholarPubMed
13.Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile—Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340–343.Google Scholar
14.Burckhardt, F, Friedrich, A, Beier, D, Eckmanns, T. Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008;14:691–692.CrossRefGoogle ScholarPubMed
15.Johnson, S, Clabots, CR, Linn, FV, Olson, MM, Peterson, LR, Gerding, DN. Nosocomial Clostridium difficile colonization and disease. Lancet 1990;336:97–100.CrossRefGoogle ScholarPubMed
16.Price, MF, Dao-Tran, T, Garey, KW, et al.Epidemiology and incidence of Clostridium difficile-associated diarrhea diagnosed upon admission to a university hospital. J Hosp Infect 2007;65:42–46.CrossRefGoogle ScholarPubMed
17.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585–1589.CrossRefGoogle ScholarPubMed